味千(中國)(00538.HK)盈喜:預計上半年純利0.8億元-1.4億元 同比大幅扭虧
格隆匯8月4日丨味千(中國)(00538.HK)公佈,與截至2022年6月30日止六個月公司擁有人應占虧損約人民幣1.065億元相比,預期集團截至2023年6月30日止六個月將錄得公司擁有人應占溢利介乎約人民幣8000萬元至1.40億萬元。
董事會認為,集團預期扭虧為盈,主要是因為集團收入較2022年同期上升及在成本控制方面取得成果。收入上升主要由於全球COVID-19疫情已經緩和,生活逐步復常,令餐廳營業額上升。另外,在COVID-19疫情期間,集團積極梳理門店,將營運未如理想之門店關閉,並積極控制營運成本,令集團整體盈利比去年同期上升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.